Department of Medical-Surgical Sciences and of Translational Medicine, Sapienza University of Rome, Nuclear Medicine Unit of S. Andrea Hospital, Via di Grottarossa 1035, 00189, Rome, Italy.
Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3430-3451. doi: 10.1007/s00259-022-05769-x. Epub 2022 Apr 4.
Consensus on optimal imaging procedure for vascular graft/endograft infection (VGEI) is still lacking and the choice of a diagnostic test is often based on the experience of single centres. This document provides evidence-based recommendations aiming at defining which imaging modality may be preferred in different clinical settings and post-surgical time window.
This working group includes 6 nuclear medicine physicians appointed by the European Association of Nuclear Medicine, 4 vascular surgeons, and 2 radiologists. Vascular surgeons formulated 5 clinical questions that were converted into 10 statements and addressed through a systematic analysis of available literature by using PICOs (Population/problem-Intervention/Indicator-Comparator-Outcome) strategy. Each consensus statement was scored for level of evidence and for recommendation grade, according to the Oxford Centre for Evidence-based Medicine criteria.
Sixty-six articles, published from January 2000 up to December 2021, were analysed and used for evidence-based recommendations.
Computed tomography angiography (CTA) is the first-line imaging modality in suspected VGEI but nuclear medicine modalities are often needed to confirm or exclude the infection. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG) has very high negative predictive value but it should be performed preferably at least 4 months after surgery to avoid false positive results. Radiolabelled white blood cell (WBC) scintigraphy, given its high diagnostic accuracy, can be performed at any time after surgery.
The European Association of Nuclear Medicine (EANM) is a professional no-profit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine. The EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice guideline, representing a policy statement by the EANM, has undergone a thorough consensus process in which it has been subjected to extensive review. The EANM recognizes that the safe and effective use of diagnostic nuclear medicine imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by those entities not providing these services is not authorized. These guidelines are an educational tool designed to assist practitioners in providing appropriate care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the EANM suggests caution against the use of the current consensus document in litigation in which the clinical decisions of a practitioner are called into question. The ultimate judgement regarding the propriety of any specific procedure or course of action must be made by the physician or medical physicist in the light of all the circumstances presented. Thus, there is no implication that an approach differing from the consensus document, standing alone, is below the standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the consensus document when, in the reasonable judgement of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the consensus document. The practice of medicine includes both the art and the science of the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognized that adherence to this consensus document will not ensure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient, to deliver effective and safe medical care. The sole purpose of this consensus document is to assist practitioners in achieving this objective.
血管移植物/血管内移植物感染(VGEI)的最佳成像程序仍存在共识,并且诊断测试的选择通常基于单个中心的经验。本文提供了循证建议,旨在确定在不同临床情况下和手术后时间窗口内哪种成像方式可能更优。
本工作组包括欧洲核医学协会任命的 6 名核医学医师、4 名血管外科医生和 2 名放射科医生。血管外科医生提出了 5 个临床问题,这些问题被转化为 10 个陈述,并通过使用 PICOS(人群/问题-干预/指标-比较-结果)策略对现有文献进行系统分析来解决。根据牛津循证医学中心的标准,对每个共识陈述进行证据水平和推荐等级评分。
分析了 2000 年 1 月至 2021 年 12 月期间发表的 66 篇文章,并将其用于循证建议。
计算机断层血管造影(CTA)是疑似 VGEI 的一线成像方式,但通常需要核医学方式来确认或排除感染。正电子发射断层扫描/计算机断层扫描(PET/CT)结合 2-脱氧-2-[F]氟-D-葡萄糖([F]FDG)具有非常高的阴性预测值,但最好在手术后至少 4 个月进行,以避免假阳性结果。放射性标记白细胞(WBC)闪烁显像因其诊断准确性高,可在手术后的任何时间进行。
欧洲核医学协会(EANM)是一个专业的非营利性医学协会,它促进了全球范围内从事核医学临床和研究卓越的个人之间的交流。EANM 成立于 1985 年。EANM 成员是专门从事核医学研究和实践的医生、技术人员和科学家。EANM 将定期为核医学实践制定新的指南,以帮助推进核医学科学,并改善全球患者的服务质量。适当情况下,将在第五周年或更早时审查现有实践指南,以进行修订或更新。每一项实践指南都代表了 EANM 的政策声明,在经过广泛审查后,都经过了彻底的共识过程。EANM 认识到,安全有效地使用诊断核医学成像需要特定的培训、技能和技术,如每一份文件所述。未经提供这些服务的实体复制或修改发布的实践指南是不被授权的。这些指南是一个教育工具,旨在帮助从业人员为患者提供适当的护理。它们不是僵化的规则或实践要求,也不是为了建立护理标准而设计的,也不应该被用来建立护理标准。出于这些原因和下文所述的原因,EANM 建议在诉讼中谨慎使用当前的共识文件,在这种情况下,从业者的临床决策受到质疑。最终,必须由医生或医学物理学家根据所有呈现的情况,对任何特定程序或治疗方案的适当性做出判断。因此,这并不意味着与共识文件单独存在的不同方法不符合护理标准。相反,当从业者根据患者的病情、可用资源的限制或随后发表的共识文件中出现的知识或技术进步,合理判断表明需要采取不同的方法时,负责任的从业者可能会采取不同的行动方案。医学实践包括预防、诊断、缓解和治疗疾病的艺术和科学。人类病情的多样性和复杂性使得不可能总是做出最恰当的诊断,也不可能总是准确预测特定的治疗反应。因此,应该认识到,遵守本共识文件并不能确保准确的诊断或成功的结果。唯一应该期望的是,从业者将遵循基于当前知识、可用资源和患者需求的合理行动方案,以提供有效和安全的医疗保健。本共识文件的唯一目的是帮助从业者实现这一目标。